Patient Enrollment in Cancer Treatment Trials About 7 Percent
By Lori Solomon HealthDay Reporter
TUESDAY, April 16, 2024 -- Patient enrollment in cancer treatment trials is 7.1 percent, higher than historical estimates, according to a study published online April 2 in the Journal of Clinical Oncology.
Joseph M. Unger, Ph.D., from the Fred Hutchinson Cancer Center in Seattle, and colleagues provided contemporary estimates of clinical trial participation among adults with cancer. The analysis included a national sample of accreditation information submitted by the 1,200 Commission on Cancer programs, which represent ≥70 percent of all U.S. cancer cases.
The researchers found that the overall estimated patient participation rate in cancer treatment trials was 7.1 percent. Participation was also seen in a wide variety of other studies, including biorepository (12.9 percent), registry (7.3 percent), genetic (3.6 percent), quality-of-life (2.8 percent), diagnostic (2.5 percent), and economic (2.4 percent) studies. For treatment trials, enrollment occurred in National Cancer Institute-designated comprehensive cancer centers (21.6 percent), academic (non–National Cancer Institute-designated) comprehensive cancer programs (5.4 percent), integrated network cancer programs (5.7 percent), and community programs (4.1 percent). Just over one in five patients participated in one or more cancer clinical research studies (21.9 percent).
"Contributions of adult patients with cancer to clinical research is more common than previously understood," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Recommendations Issued for Palliative RT for Symptomatic Bone Mets
THURSDAY, May 30, 2024 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published online May 22 in Practical Radiation Oncology...
Living Outside of Comprehensive Cancer Center Catchment Area Tied to Later-Stage Diagnosis
TUESDAY, May 28, 2024 -- Disadvantaged populations and those living outside of a comprehensive cancer center's main catchment area have higher odds of receiving a diagnosis of...
Disparities Seen in Cancer Treatment Delivery at Minority-Serving Hospitals
TUESDAY, May 28, 2024 -- There are systemic disparities in definitive cancer treatment delivery at minority-serving hospitals (MSHs) versus non-MSHs, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.